Bolt Biotherapeutics Completes Prana Merger and $120 Million Financing
Bolt completed its merger with Prana Therapies on October 23, issuing Prana equityholders common and Series D preferred shares. Bolt also agreed to sell $120 million of preferred shares and warrants in a private placement expected to close October 26.
Bolt Biotherapeutics completed its merger with Prana Therapies on October 23, 2026, issuing common and Series D preferred shares to Prana equityholders. Bolt also agreed to sell $120 million of preferred shares and warrants in a private placement, which is expected to close October 26. Full cash exercise of the